Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT02087943 · COMPLETED
Trial details
- NCT number
- NCT02087943
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.